Pharmacological Modulation Of Novel Molecular Systems In The Management Of Patients With Complex Pathologies

Friday, October 27th / 14.30-15.30
143 Inhibition of cyclin-dependent kinase 4/6: new perspectives in the breast cancer ER+/HER2-
Romano Danesi
146 Innovation in the treatment of patients with severe infections caused by Multi-Drug Resistant bacteria (MDR)
Federico Pea
193 The future of chronic inflammatory diseases' treatment: JAK pathway, a new mechanism
Corrado Blandizzi